Tag: tiotropium

Section 3(D) of Indian Patent Act Strikes Again

27th July, 2015 - 5:24 am Categories: India News & Updates patent infringement Patent Opposition Patents pharma Section 3(D) 0 Comments

India revoked yet another drug patent granted to a German MNC, Boehringer Ingelheim, for its respiratory drug, Spiriva (crystalline tiotropium bromide monohydrate) at a time when the US is putting pressure on the Indian government for not providing adequate patent protection to multinational drug companies. In its decision, the patent office held that Boehringer failed … Continue reading Section 3(D) of Indian Patent Act Strikes Again